Update on Emerging Treatment Options for Primary Biliary Cholangitis

Primary biliary cholangitis (PBC) is a rare autoimmune cholestatic liver disease that may progress to fibrosis or cirrhosis. Treatment options are currently limited. Ursodeoxycholic acid (UDCA) remains first-line therapy and has been proven to normalize serum biochemistries, halt histologic disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar, Maria T, Chascsa, David M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259454/
https://www.ncbi.nlm.nih.gov/pubmed/32547264
http://dx.doi.org/10.2147/HMER.S205431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259454/
https://www.ncbi.nlm.nih.gov/pubmed/32547264
http://dx.doi.org/10.2147/HMER.S205431

Ejemplares similares